With 30+ years of freeze-drying experience and more than 3000 formulations developed, Biopharma Group has more than tripled its freeze-drying production capacity over the past 18 months, enabling it to manage anything from small one-off R&D and production runs, through to on-going production scale projects.
Using its dedicated R&D facilities, the company’s in-house lyo scientists can freeze dry products in a variety of formats from vials, well-plates, in bulk or as lyobeads. Lyobeads are proving particularly popular in the field of diagnostics and vaccines – with scope to produce a million units in a week at Biopharma Group’s ISO 13485 accredited facility for assembly and packing in a controlled environment.
Diagnostics including PCR, vaccines, pharmaceuticals, food & nutraceuticals or biotech are in scope, and include projects for small molecules, nucleic acids, proteins, bacteria and biomaterials. Sensitive projects such as cytotoxics can be handled a separate standalone facility with dedicated equipment.
When the time comes for scaling-up (or down), help is on hand to meet new requirements – from reassessing the formulation, process review and cycle development to validations and contract liquid fill and powder filling services to make things run as smoothly and efficiently as possible.
Get in touch to discuss your requirements today, or visit: www.intelligentfreezedrying.com
